ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04520	Adherens junction	9/94	103/7206	6.80216754699e-06
ko04144	Endocytosis	15/94	342/7206	3.1170779293e-05
ko05200	Pathways in cancer	18/94	492/7206	5.27403008296e-05
ko04066	HIF-1 signaling pathway	7/94	123/7206	0.00106599698504
ko05206	MicroRNAs in cancer	8/94	177/7206	0.00208420545703
ko04390	Hippo signaling pathway	8/94	188/7206	0.00303310924624
ko05215	Prostate cancer	6/94	111/7206	0.0031657992402
ko04015	Rap1 signaling pathway	10/94	278/7206	0.00320770006432
ko05220	Chronic myeloid leukemia	5/94	85/7206	0.00489623377594
ko04391	Hippo signaling pathway - fly	5/94	90/7206	0.0062349295135
ko05211	Renal cell carcinoma	5/94	96/7206	0.00815874757476
ko04530	Tight junction	8/94	228/7206	0.00954741177134
ko00310	Lysine degradation	4/94	73/7206	0.0148986507183
ko05214	Glioma	4/94	79/7206	0.0193924383098
ko04550	Signaling pathways regulating pluripotency of stem cells	6/94	165/7206	0.0204540839789
ko05212	Pancreatic cancer	4/94	83/7206	0.0228080787235
ko05218	Melanoma	4/94	85/7206	0.0246450712094
ko05224	Breast cancer	6/94	174/7206	0.0257695064507
ko04014	Ras signaling pathway	8/94	279/7206	0.0286960561988
ko03015	mRNA surveillance pathway	4/94	93/7206	0.0328729207134
ko04120	Ubiquitin mediated proteolysis	5/94	138/7206	0.0338644613484
ko05202	Transcriptional misregulation in cancer	6/94	188/7206	0.0357519903457
ko04010	MAPK signaling pathway	9/94	321/7206	0.0370341772111
ko00900	Terpenoid backbone biosynthesis	2/94	24/7206	0.038578661836
ko04080	Neuroactive ligand-receptor interaction	1/94	423/7206	0.0438710745672
ko04350	TGF-beta signaling pathway	4/94	103/7206	0.0451736523257
ko04330	Notch signaling pathway	3/94	62/7206	0.046800269187
ko01521	EGFR tyrosine kinase inhibitor resistance	4/94	106/7206	0.0493038858609